Salbutamol Completed Phase 3 Trials for Persistent Asthma Treatment

CompletedTreatment3 IdentifierTitleDrugs
NCT02040779A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
NCT02513160Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma